Suppgenie: What do the studies say about using L-Theanine for sleep? What is an affective does ?

Summary:
Human clinical trials and reviews indicate that L-theanine may improve subjective sleep quality—primarily by reducing anxiety and promoting relaxation, rather than acting as a sedative. An effective oral dose supported by several studies and reviews is 200 mg taken before bed. Studies at 250–400 mg/day have also been explored in populations with comorbid anxiety, depressive disorders, or schizophrenia, with improvement in sleep quality consistently related to L-theanine’s anxiolytic effects.

---

Details:
Key Human Research (Relevant Dosages and Effects on Sleep):

1. Systematic Review – Rao et al., JACN 2015

   • Design: Summary of multiple human studies (including actigraphy, sleep questionnaires, ANS monitoring).
   • Dose: 200 mg L-theanine before bed.
   • Population: Adults and children, some with sleep complaints.
   • Effects: Improved sleep quality via reduction in anxiety (not direct sedation), better WASO scores, improved parasympathetic activity, and subjective sleep markers.
   • Safety: No adverse events at 200 mg; NOAEL (no observed adverse effect level) above 2000 mg/kg in animal models.

2. Open-Label Clinical Trial – Hidese et al., Acta Neuropsychiatrica 2017

   • Design: 8-week open-label supplementation.
   • Dose: 250 mg/day.
   • Population: 20 patients with major depressive disorder.
   • Effects: Statistically significant improvements on the Pittsburgh Sleep Quality Index (PSQI), as well as anxiety and depression scores.
   • Compliance/Limitations: Not placebo-controlled; findings need confirmation in RCTs.

3. Randomized Controlled Trials/Neurocognitive Studies (Doses 200–400 mg):

   • These studies typically used L-theanine for cognitive/attentional effects but also measured anxiety and sleep outcomes as secondary endpoints. Where reported, these doses were safe and associated with improved subjective sleep quality.

---

Research Notes:

• Several animal studies support L-theanine’s sleep-improving effects especially by counteracting caffeine-induced sleep disruption.
• Main mechanism is anxiolysis (promotion of relaxation and decreased stress), which supports better sleep onset and maintenance without causing next-day drowsiness.
• Safety profile is robust; published adverse events at effective sleep-related doses (200–400 mg) are rare or absent.

Compliance Note:

• US (FDA): “Supports relaxation” and “may help reduce occasional stress to support sleep quality” are generally acceptable structure/function claims, but “treats insomnia” or “induces sleep” is NOT compliant for supplements.
• EU (EFSA): No approved sleep claims specific for L-theanine; “relaxation” claims require documented human evidence and careful wording to avoid therapeutic claims.

---

Key Doses Supported by Evidence (For Sleep):

• 200 mg L-theanine (most commonly studied, before bed)
• Up to 400 mg/day has been used in studies on populations with concurrent psychiatric symptoms
• No significant risk for adverse effects at these doses in clinical trials.

---

Summary Table:

---

Bottom Line:
Robust human data support 200 mg L-theanine (taken before bed) as a safe, effective dose for supporting better sleep quality through relaxation and anxiety reduction. Larger or longer-term studies may use up to 400 mg, but most marketing claims should emphasize “relaxation” and “sleep quality” rather than direct sleep induction, due to regulatory constraints.

References (for citation):

• Rao TP et al., J Am Coll Nutr. 2015;34(5):436-447. doi:10.1080/07315724.2014.926153
• Hidese S et al., Acta Neuropsychiatr. 2017;29(5):291-299. doi:10.1017/neu.2016.33

Let me know if you need sample compliant marketing language or additional regulatory details!